RECCORD (Recording Courses of Vascular Diseases) Registry

Deutsche Gesellschaft für Angiologie, Gesellschaft für Gefäßmedizin e.V.

Status: Enrolling

Conditions: Claudication; Diabetic Foot; Peripheral Artery Disease; Critical Limb Ischemia; Vascular Diseases

Study type: Observational

Funder types: Other

Identifiers

NCT03448029

U1111-1209-6562 (Other Identifier)

RECCORD

DRKS00013585 (Registry Identifier)

Details and patient eligibility

About

The RECording COurses of vasculaR Diseases registry (RECCORD registry) is an observational, prospective, multicentre, all-comers registry platform.

In the initial phase, patients referred for endovascular revascularization of peripheral artery disease (PAD) of the lower limbs will be prospectively included and followed up for at least one year.

At baseline, data on patients' demographic characteristics, comorbidities, previous peripheral interventions, medication, and clinical stage of PAD (Rutherford category), haemodynamic parameters, and procedural data including complications will be assessed.

Major adverse cardiac and limb events will be recorded at planned (at six and 12 months) and at any unplanned visits.

For details see NM Malyar et al., Rationale and design of the RECording COurses of vasculaR Diseases registry (RECCORD registry). Vasa. https://doi.org/10.1024/0301-1526/a000631

Full description

For details see NM Malyar et al., Rationale and design of the RECording COurses of vasculaR Diseases registry (RECCORD registry). Vasa.

https://doi.org/10.1024/0301-1526/a000631

Enrollment: 6,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• any type of endovascular interventions for symptomatic PAD
• endovascular intervention for PAD of lower extremities, i.e. below the aorto-iliac bifurcation

Exclusion criteria

• patients undergoing hybrid-(surgical and endovascular) and/or surgical interventions for symptomatic PAD
• patients with a life expectancy of <6 months
• endovascular intervention for reasons other than symptomatic PAD

Trial design

6,000 participants in 1 patient group

Endovascular Patients

Description:

Patients undergoing endovascular interventions for symptomatic PAD